Viewing Study NCT03906695


Ignite Creation Date: 2025-12-24 @ 2:03 PM
Ignite Modification Date: 2026-02-09 @ 7:49 AM
Study NCT ID: NCT03906695
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-20
First Post: 2019-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module